You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 7, July 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Depression
 •Psychotherapy
 •Alert me on articles by topic

Neuroimaging Profiles and the Differential Therapies of Depression

Arch Gen Psychiatry. 2001;58:651-653.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE ARTICLES by Brody et al1 and Martin et al,2 published in this issue of the ARCHIVES, provide intriguing, albeit preliminary, new data on the functional neuroanatomy of depression. Using single-photon emission computed tomography (SPECT)2 and 18F-fluorodeoxyglucose positron emission tomography (PET)1 neuroimaging methods, outpatients with major depressive disorder were studied before and after treatment. What distinguishes these reports from earlier neuroimaging investigations using pretreatment and posttreatment designs is that both studies compared the effects of pharmacotherapy with those of interpersonal psychotherapy (IPT), one of the better studied psychosocial treatments of depression. The report of Brody et al1 is further distinguished by inclusion of a healthy control group, also studied at 2 time points. Results indicated that both treatments were associated with increased blood flow to the left temporal1 or right basal ganglia2 regions. Moreover, in the study of Brody et al1 both IPT and paroxetine treatment normalized metabolism in the . . . [Full Text of this Article]


RELATED ARTICLES

Regional Brain Metabolic Changes in Patients With Major Depression Treated With Either Paroxetine or Interpersonal Therapy: Preliminary Findings
Arthur L. Brody, Sanjaya Saxena, Paula Stoessel, Laurie A. Gillies, Lynn A. Fairbanks, Shervin Alborzian, Michael E. Phelps, Sung-Cheng Huang, Hsiao-Ming Wu, Matthew L. Ho, Mai K. Ho, Scott C. Au, Karron Maidment, and Lewis R. Baxter, Jr
Arch Gen Psychiatry. 2001;58(7):631-640.
ABSTRACT | FULL TEXT  

Brain Blood Flow Changes in Depressed Patients Treated With Interpersonal Psychotherapy or Venlafaxine Hydrochloride: Preliminary Findings
Stephen D. Martin, Elizabeth Martin, Santoch S. Rai, Mark A. Richardson, and Robert Royall
Arch Gen Psychiatry. 2001;58(7):641-648.
ABSTRACT | FULL TEXT  

Functional Brain Circuits in Major Depression and Remission
Harold A. Sackeim
Arch Gen Psychiatry. 2001;58(7):649-650.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Self-Control as an Executive Function: Reformulating Gottfredson and Hirschi's Parental Socialization Thesis
Beaver et al.
Criminal Justice and Behavior 2007;34:1345-1361.
ABSTRACT  

Drs. Kay and Gabbard Reply
KAY and GABBARD
Am. J. Psychiatry 2003;160:186-186.
FULL TEXT  

Diagnosis and management of depression in primary care: a clinical update and review
Remick
CMAJ 2002;167:1253-1260.
ABSTRACT | FULL TEXT  

Functional Neuroanatomy of Remission from Depression
JWatch Psychiatry 2001;2001:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.